KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Invested Capital (2020 - 2025)

Novavax (NVAX) has 8 years of Return on Invested Capital data on record, last reported at 3.22% in Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 368.0% year-over-year to 3.22%; the TTM value through Dec 2025 reached 3.22%, down 368.0%, while the annual FY2025 figure was 1.21%, 160.0% down from the prior year.
  • Return on Invested Capital reached 3.22% in Q4 2025 per NVAX's latest filing, up from 5.03% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 9.06% in Q1 2022 and bottomed at 31.28% in Q4 2021.
  • Average Return on Invested Capital over 5 years is 1.77%, with a median of 0.48% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: soared 3236bps in 2022, then crashed -1858bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 31.28% in 2021, then surged by 103bps to 1.08% in 2022, then dropped by -25bps to 0.82% in 2023, then tumbled by -44bps to 0.46% in 2024, then plummeted by -801bps to 3.22% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 3.22% in Q4 2025, 5.03% in Q3 2025, and 18.12% in Q2 2025.